Photoinduction of Ferroptosis and cGAS-STING Activation by a H 2 S-Responsive Iridium(III) Complex for Cancer-Specific Therapy
Journal of Medicinal Chemistry · 2024
DOI: 10.1021/acs.jmedchem.4c01065 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Yi Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Theoretical Organic Chemistry and Function Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan Uni…. Hauptthemen laut MEDLINE: Ferroptosis, Iridium, Nucleotidyltransferases, Membrane Proteins. Die Arbeit wurde bisher 42-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (Originalsprache)
Triggering ferroptosis represents a promising anticancer therapeutic strategy, but the development of a selective ferroptosis inducer for cancer-specific therapy remains a great challenge. Herein, a H2S-responsive iridium(III) complex NA-Ir has been well-designed as a ferroptosis inducer. NA-Ir could selectively light up H2S-rich cancer cells, primarily localize in mitochondria, intercalate into mitochondrial DNA (mtDNA), and induce mtDNA damage, exhibiting higher anticancer activity under light irradiation. Mechanistic studies showed that NA-Ir-mediated PDT triggered lipid peroxidation and glutathione peroxidase 4 downregulation through ROS production and GSH depletion, resulting in ferroptosis through multiple pathways. Moreover, the intense mtDNA damage can activate the cyclic GMP-AMP synthase-stimulator of the interferon gene (cGAS-STING) pathway, leading to ferritinophagy and further ferroptosis. RNA-sequencing analysis showed that NA-Ir-mediated PDT mainly affects the expression of genes related to ferroptosis, autophagy, and cancer immunity. This study demonstrates the first cancer-specific example with ferroptosis and cGAS-STING activation, which provides a new strategy for multimodal synergistic therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Theoretical Organic Chemistry and Function Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan 411201, P. R. China.
- Centre for Translational Medicine Research & Development, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, P. R. China.
- MOE Key Laboratory of Bioinorganic and Synthetic Chemistry, School of Chemistry, IGCME, Sun Yat-Sen University, Guangzhou 510275, P. R. China.
ORCID-Profile: Yi Li, Wei Zhang, Yu-Xiao Lai, Zong-Wan Mao
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
- Shenzhen Medical Research Funds
Zitieren
APA
Li, Y., Liu, B., Zheng, Y., Hu, M., Liu, L. Y., Li, C. R., Zhang, W., Lai, Y. X., & Mao, Z. W. (2024). Photoinduction of Ferroptosis and cGAS-STING Activation by a H 2 S-Responsive Iridium(III) Complex for Cancer-Specific Therapy. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01065
Vancouver
Li Y, Liu B, Zheng Y, Hu M, Liu LY, Li CR, et al. Photoinduction of Ferroptosis and cGAS-STING Activation by a H 2 S-Responsive Iridium(III) Complex for Cancer-Specific Therapy. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c01065
BibTeX
@article{Li2024,
author = {Li, Yi and Liu, Ben and Zheng, Yue and Hu, Meng and Liu, Liu-Yi and Li, Cai-Rong and Zhang, Wei and Lai, Yu-Xiao and Mao, Zong-Wan},
title = {Photoinduction of Ferroptosis and cGAS-STING Activation by a H 2 S-Responsive Iridium(III) Complex for Cancer-Specific Therapy},
journal = {Journal of Medicinal Chemistry},
year = {2024},
doi = {10.1021/acs.jmedchem.4c01065}
}
EUVIMED